Company Profiles

driven by the PitchBook Platform

RhinoCyte

Description

Developer of a regenerative therapy designed to treat degenerative and traumatic neurological diseases. The company's regenerative therapy repairs life-altering or even life-threatening damage resulting from spinal cord injury and neurological disorders such as Parkinson's disease, amyotrophic lateral sclerosis (ALS), multiple sclerosis and Type 1 diabetes, using stem cells, enabling patients suffering from a neurological disorder to get proper treatment.

2005

Founded

OOB

Status

Out of Business

Latest Deal Type

$11.7M

Total Amount Raised

Description

Developer of a regenerative therapy designed to treat degenerative and traumatic neurological diseases. The company's regenerative therapy repairs life-altering or even life-threatening damage resulting from spinal cord injury and neurological disorders such as Parkinson's disease, amyotrophic lateral sclerosis (ALS), multiple sclerosis and Type 1 diabetes, using stem cells, enabling patients suffering from a neurological disorder to get proper treatment.

Website:

www.rhinocyte.com

Ownership Status

Out of business

Financing Status

Formerly VC-Backed

Primary Industry

Therapeutic Devices

Other Industries

Biotechnology

Primary Office

1044 East Chestnut Street Louisville, KY 40204United States +1 (502) 410-4512
    Request a free trial to the PitchBook Platform
    You're viewing a free company profile from the PitchBook Platform. To explore RhinoCyte's full profile, request a free trial.

    RhinoCyte Valuation and Funding

    Request access
    Deal TypeDateAmountRaised to DatePost-ValStatusStage

    RhinoCyte Cap Table

    Stock# of Shares
    Authorized
    Par ValueDividend Rate (%)Original
    Issue Price
    LiquidationLiquidation
    Pref. Multiple
    Conversion
    Price
    % Owned

    RhinoCyte Executive Team (2)

    NameTitleBoard
    Seat
    Contact
    Info
    Fred Roisen Ph.DCo-Founder, Board Member & Chief Scientific Officer
    Steve GailarCo-Founder, Board Member & Advisor
    Fred Roisen Ph.D Co-Founder, Board Member & Chief Scientific Officer
    Steve Gailar Co-Founder, Board Member & Advisor

    RhinoCyte Board Members (1)

    NameRepresentingRoleSinceContact
    Info
    Michael CurtinSelfBoard Member000 0000
    Michael Curtin Board Member Self
    Request full access to PitchBook